| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 2e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |